...Richard Cookson Abstract In 2009 the UK National Institute for Health and Clinical Excellence (NICE) announced that its health technology appraisal committees would henceforth give special additional weight to health gains from life-extending end-of-life treatments. This was a response to mounting...

... in the light of the pressures created by demographic changes, rising patient expectations, and technological advances (Wanless 2002). A key component of the Blair government’s strategy for addressing this dual challenge is the work undertaken by the National Institute for Clini- cal Excellence (NICE...

...-in-the-effective-health-care-program1/ahrq-community-forum/?keywords=community%20forum (accessed November 5, 2011) . Amis L. 2009 . “Patient Involvement in NICE Technology Appraisals.” In Patients, the Public, and Priorities in Healthcare , edited by Littlejohns P. Rawlins M. , 29 – 38...

...Figure 1 Reasons for NICE Restrictions: Percentage of Drug Evaluations ( N =24) Source: Adapted from Mason and Drummond 2009 ...

... can make the best use of its resources to improve patient health. Moreover, the inadequacies of the PPRS have other unin- tended effects for both the NHS and health care in other countries. Since 1999, the National Institute for Health and Clinical Excellence (NICE) has conducted cost...

... ): 11 – 29 . Donelan K. Blendon R. J. Schoen C. Davis K. Binns K. . 1999 . The Cost of Health System Change: Public Discontent in Five Nations . Health Affairs 18 ( 3 ): 206 – 216 . Drummond M. F. Sorenson C. . 2009 . Can NICE Be Nicer? Value...

..., for example, the National Institute for Health and Care Excellence (NICE) and the King's Fund to grapple with lessons learned from the UK experience. Given this contrast, I was immediately intrigued by the possibility of creating a special issue from the conference papers. Adam agreed to collaborate as guest...

... in the NHS single-payer model facilitates a relatively easy introduction of economic evaluation-informed national guidance com- pared to other systems of health care, and it is probably true to say that the National Institute for Health and Clinical Excellence (NICE), which assesses selected...

...), England launched the National Institute for Health and Clinical Excellence (NICE), which has established itself as one of the leading agencies for economic evaluation of health technology in the world. Since then, Canada, Australia, and several European countries have started using formal economic...

... Journal of Medicine 324 : 1362 -1365. Mulrow, C. D. 1987 . The Medical Review Article: State of the Science. Annals of Internal Medicine 106 : 485 -488. Nasty Start. 1999 . A Nasty Start for NICE (editorial). Lancet 354 : 1313 . Rennie, D., and H. S. Luft. 2000 . Pharmaco-Economic...

... drug varies with the manner in which it conducts the cost-effectiveness analysis or comparative-effectiveness analysis. In the United Kingdom, the National Institute for Health Care Excellence (NICE) analyzes the cost-effectiveness of drugs and determines whether the manufacturer's charge (its net...

... to create an HTA organization that appraised new technologies for the NHS. The culmination of this was the creation of the National Institute for Health and Clinical Excellence (NICE) in 1999. NICE currently has three roles: the economic evaluation of new pharmaceuticals and devices; the production of cost...

... frameworks are to a great extent legitimized by the work of NICE. There was little to no resistance to the idea of developing a CEA-like model and in defining value for money as the ratio between health gains and costs. Second, the interventions or services being assessed should target a relatively...

... in decision- making, the influence of cultural traditions in a contemporary professional setting, and the nature of bureaucracy). The text strikes a nice balance of empirical description, theoretically informed analysis, and interesting case-studies and anecdotes; it is also very nicely punctu...

..., which includes sources of revenue and the progressivity or regressivity of those sources, and so both horizontal and vertical equity. * Coverage, which he very nicely defines in terms of breadth (across the population), scope (which benefits are covered), and depth (what proportion of the cost...

... has taken on a com- plicated, difficult task. He makes a noble effort, bringing together an impressive array of source material and nicely synthesizing recent political analyses of the U.S. political scene. He draws on sources as wide-ranging as William Ryan, C. E. A. Winslow, Benjamin Rush...

... of cultural traditions in a contemporary professional setting, and the nature of bureaucracy). The text strikes a nice balance of empirical description, theoretically informed analysis, and interesting case-studies and anecdotes; it is also very nicely punctu- ated with maps, charts, and photographs...

... with Multiple Sclerosis . February 4. www.dh.gov.uk/assetRoot/04/01/22/14/04012214.pdf . Devlin, N., and D. Parkin. 2004 . Does NICE Have a Cost-Effectiveness Threshold and What Other Factors Influence Its Decisions? A Binary Choice Analysis. Health Economics 13 : 437 -452. Dolan, P. 1998...

... with systems in Germany, Canada, and the United Kingdom. This book nicely illustrates the complexity of the American health care system. It carefully describes the fundamental components of the system for patients and health care providers (predominantly physicians). It also introduces many important...